Directory › Catalent

Catalent — Kansas City

Kansas City, Missouri, United States · CDMO

This is a record of what regulators published, not a rating.

Site facts

Company
Catalent
Name(s) in FDA data
Catalent CTS, LLC
FEI number(s)
3002929455 (present in FDA Data Dashboard records for this name and city)
Location (as in FDA data)
Kansas City, Missouri, United States 64137
Records matched
8 FDA inspections
Most recent FDA inspection in dataset
04 Mar 2022 — NAI

Capabilities (from the company's website)

  • Highly potent (HPAPI)
    …ies such as controlled drug storage and handling, enabling the site to manage complex and high-potency clinical products with precision and compliance. Site Capabilities Clinical Supply Servic…
  • Clinical trial supply & packaging
    …Location Hub Kansas City - Clinical Supply Missouri, United States Catalent's Kansas City facility offers comprehensive clinical pa…

Taken from the company's web page for this site. Source: https://www.catalent.com/locations/kansas-city-united-states-css, checked 16 Oct 2026. Quoted text shows the wording each tag is based on.

Regulatory timeline

Newest first. Each entry links to the published source. Inspection classifications: NAI = no action indicated, VAI = voluntary action indicated, OAI = official action indicated (FDA definitions). Posted 483 citations are FDA's short summaries, not the full Form 483.

  1. 04 Mar 2022
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002929455, inspection ID 1165575)

  2. 06 Nov 2017
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs, Veterinary. Project area(s): Drug Quality Assurance; Monitoring of Marketed Animal Drugs, Feed, and Devices.

    Source: FDA Data Dashboard – Inspections (FEI 3002929455, inspection ID 1031493)

  3. 29 Jun 2015
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs, Veterinary. Project area(s): Drug Quality Assurance; Monitoring of Marketed Animal Drugs, Feed, and Devices.

    Source: FDA Data Dashboard – Inspections (FEI 3002929455, inspection ID 932408)

  4. 10 Nov 2014
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002929455, inspection ID 902815)

  5. 05 Mar 2014
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002929455, inspection ID 869225)

  6. 14 Jan 2013
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002929455, inspection ID 815514)

  7. 08 Jun 2012
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002929455, inspection ID 786631)

  8. 24 Mar 2010
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs, Veterinary. Project area(s): Drug Quality Assurance; Monitoring of Marketed Animal Drugs, Feed, and Devices.

    Source: FDA Data Dashboard – Inspections (FEI 3002929455, inspection ID 653408)

This is a record of what regulators published, not a rating. Absence of a record here does not mean no record exists; see methodology for what we check and how records are matched.